Zhejiang Shouxiangu Pharmaceutical Co Ltd Class A 603896
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 27.34
- Day Range
- CNY 27.10–27.76
- 52-Week Range
- CNY 23.07–48.08
- Bid/Ask
- CNY 27.42 / CNY 27.43
- Market Cap
- CNY 5.54 Bil
- Volume/Avg
- 2.6 Mil / 2.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 22.53
- Price/Sales
- 6.74
- Dividend Yield (Trailing)
- 1.60%
- Dividend Yield (Forward)
- 1.60%
- Total Yield
- 1.60%
Company Profile
Zhejiang Shouxiangu Pharmaceutical Co Ltd is a Chinese pharmaceutical company.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,051
- Website
- http://www.sxg1909.com
Comparables
Valuation
|
Metric
|
603896
|
688192
|
301277
|
|---|---|---|---|
Price/Earnings (Normalized) | 22.53 | — | 30.79 |
Price/Book Value | 2.45 | 24.33 | 3.14 |
Price/Sales | 6.74 | 96.76 | 7.13 |
Price/Cash Flow | 18.86 | — | 19.60 |
Price/Earnings
603896
688192
301277
Financial Strength
|
Metric
|
603896
|
688192
|
301277
|
|---|---|---|---|
Quick Ratio | 3.29 | 1.59 | 6.81 |
Current Ratio | 3.64 | 1.80 | 7.09 |
Interest Coverage | 12.27 | −100.52 | 1,738.22 |
Quick Ratio
603896
688192
301277
Profitability
|
Metric
|
603896
|
688192
|
301277
|
|---|---|---|---|
Return on Assets (Normalized) | 7.77% | −66.38% | 9.49% |
Return on Equity (Normalized) | 11.42% | −99.78% | 10.73% |
Return on Invested Capital (Normalized) | 7.56% | −78.11% | 10.58% |
Return on Assets
603896
688192
301277
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Ppvmjvhvy | Gvtxn | $567.0 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Zwcrksstw | Vxncg | $109.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Fjvblrnq | Wzdrxk | $105.3 Bil | |
MRNA
| Moderna Inc | Yrmbgsqc | Kspz | $47.0 Bil | |
ARGX
| argenx SE ADR | Zvvfsvxh | Fjzm | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Qqdyflpl | Ykbgs | $22.1 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Zppwhdb | Lldpfcd | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Dyycdshw | Fxblk | $15.5 Bil | |
RPRX
| Royalty Pharma PLC Class A | Hqhzzbxm | Gwtdmtd | $12.7 Bil | |
INCY
| Incyte Corp | Wctcpzkl | Jpgfnt | $12.0 Bil |